Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Vitamin A and apoptosis in prostate cancer.

Zhang XK.

Endocr Relat Cancer. 2002 Jun;9(2):87-102. Review.

2.

Targeting Nur77 translocation.

Zhang XK.

Expert Opin Ther Targets. 2007 Jan;11(1):69-79. Review.

PMID:
17150035
3.

The prospects of retinoids in the treatment of prostate cancer.

Hammond LA, Brown G, Keedwell RG, Durham J, Chandraratna RA.

Anticancer Drugs. 2002 Sep;13(8):781-90. Review. Erratum in: Anticancer Drugs. 2002 Nov;13(10):1077-8.

PMID:
12394261
4.

Receptor-independent induction of apoptosis by synthetic retinoids.

Lotan R.

J Biol Regul Homeost Agents. 2003 Jan-Mar;17(1):13-28. Review.

PMID:
12757019
5.

Natural and synthetic retinoids in prostate cancer.

Pasquali D, Rossi V, Bellastella G, Bellastella A, Sinisi AA.

Curr Pharm Des. 2006;12(15):1923-9. Review.

PMID:
16724957
6.

p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction.

Moll UM, Marchenko N, Zhang XK.

Oncogene. 2006 Aug 7;25(34):4725-43. Review.

PMID:
16892086
7.

The apoptotic action of the retinoid CD437/AHPN: diverse effects, common basis.

Zhao X, Spanjaard RA.

J Biomed Sci. 2003 Jan-Feb;10(1):44-9. Review.

PMID:
12566985
8.

Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?

Tahmatzopoulos A, Kyprianou N.

Prostate. 2004 Apr 1;59(1):91-100. Review.

PMID:
14991869
9.
10.

Gonadotropin-releasing hormone in apoptosis of prostate cancer cells.

Kraus S, Naor Z, Seger R.

Cancer Lett. 2006 Mar 28;234(2):109-23. Epub 2005 Apr 25. Review.

PMID:
16546667
11.

Mechanisms of prostate cancer cell survival after inhibition of AR expression.

Cohen MB, Rokhlin OW.

J Cell Biochem. 2009 Feb 15;106(3):363-71. doi: 10.1002/jcb.22022. Review.

PMID:
19115258
12.

Novel targeting of apoptosis pathways for prostate cancer therapy.

Garrison JB, Kyprianou N.

Curr Cancer Drug Targets. 2004 Feb;4(1):85-95. Review.

PMID:
14965270
13.

Facts and future lines of research in prostate cancer: concluding remarks.

Abrams P.

BJU Int. 2000 Apr;85 Suppl 2:49-51. Review. No abstract available.

Supplemental Content

Support Center